skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
08/28/2018
Application #:
15533076
Filing Dt:
06/05/2017
Publication #:
Pub Dt:
11/09/2017
Inventors:
Young Dae Gong, Se Hun Kwak, Eun Sil Lee
Title:
SUBSTITUTED THIENO[3,2-b]PYRAZINES FOR INHIBITING CANCER CELL PROLIFERATION AND INDUCING CANCER CELL APOPTOSIS
Assignment: 1
Reel/Frame:
042923/0283Recorded: 07/06/2017Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
06/26/2017
Exec Dt:
06/26/2017
Exec Dt:
06/26/2017
Assignee:
30, PILDONG-RO 1-GIL, JUNG-GU
SEOUL, KOREA, REPUBLIC OF 04620
Correspondent:
LAURA DACONCEICAO
CHALKER FLORES, LLP
14951 NORTH DALLAS PARKWAY, SUITE 400
DALLAS, TX 75254
Assignment: 2
Reel/Frame:
049300/0498Recorded: 05/29/2019Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/24/2019
Assignee:
(CHUNGMU-RO 1GA, CORYO DAEYUNGAK TOWER), #1301-1, 13F
97, TOEGYE-RO, JUNG-GU
SEOUL, KOREA, REPUBLIC OF 04535
Correspondent:
LAURA DACONCEICAO
CHALKER FLORES, LLP
14951 NORTH DALLAS PARKWAY, SUITE 400
DALLAS, TX 75254
Assignment: 3
Reel/Frame:
061254/0800Recorded: 08/19/2022Pages: 3
Conveyance:
NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/14/2022
Assignee:
51-9, DONGTANCHEOMDANSANEOP 1-RO, HWASEONG-SI
GYEONGGI-DO, KOREA, REPUBLIC OF
Correspondent:
CPA GLOBAL LIMITED
LIBERATION HOUSE
CASTLE STREET
ST HELIER, JE1 1BL JERSEY

Search Results as of: 06/25/2024 01:30 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT